vs

Side-by-side financial comparison of AVIAT NETWORKS, INC. (AVNW) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

AVIAT NETWORKS, INC. is the larger business by last-quarter revenue ($111.5M vs $83.1M, roughly 1.3× PROCEPT BioRobotics Corp). AVIAT NETWORKS, INC. runs the higher net margin — 5.1% vs -38.1%, a 43.2% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -5.7%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 0.3%).

Aviat Networks, Inc. is a global provider of microwave transport and backhaul solutions, providing public and private operators with communications infrastructure to serve telecommunications operators and enterprise customers.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

AVNW vs PRCT — Head-to-Head

Bigger by revenue
AVNW
AVNW
1.3× larger
AVNW
$111.5M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+25.9% gap
PRCT
20.2%
-5.7%
AVNW
Higher net margin
AVNW
AVNW
43.2% more per $
AVNW
5.1%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
0.3%
AVNW

Income Statement — Q2 FY2026 vs Q1 FY2026

Metric
AVNW
AVNW
PRCT
PRCT
Revenue
$111.5M
$83.1M
Net Profit
$5.7M
$-31.6M
Gross Margin
32.4%
64.9%
Operating Margin
6.5%
-4.1%
Net Margin
5.1%
-38.1%
Revenue YoY
-5.7%
20.2%
Net Profit YoY
27.2%
-27.9%
EPS (diluted)
$0.44
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AVNW
AVNW
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$111.5M
$76.4M
Q3 25
$107.3M
$83.3M
Q2 25
$115.3M
$79.2M
Q1 25
$112.6M
$69.2M
Q4 24
$118.2M
$68.2M
Q3 24
$88.4M
$58.4M
Q2 24
$116.7M
$53.4M
Net Profit
AVNW
AVNW
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$5.7M
$-29.8M
Q3 25
$162.0K
$-21.4M
Q2 25
$5.2M
$-19.6M
Q1 25
$3.5M
$-24.7M
Q4 24
$4.5M
$-18.9M
Q3 24
$-11.9M
$-21.0M
Q2 24
$1.5M
$-25.6M
Gross Margin
AVNW
AVNW
PRCT
PRCT
Q1 26
64.9%
Q4 25
32.4%
60.6%
Q3 25
33.2%
64.8%
Q2 25
34.2%
65.4%
Q1 25
34.9%
63.9%
Q4 24
34.6%
64.0%
Q3 24
22.4%
63.2%
Q2 24
35.3%
59.0%
Operating Margin
AVNW
AVNW
PRCT
PRCT
Q1 26
-4.1%
Q4 25
6.5%
-40.6%
Q3 25
4.8%
-27.8%
Q2 25
7.7%
-28.0%
Q1 25
8.3%
-39.7%
Q4 24
6.7%
-28.9%
Q3 24
-17.6%
-38.4%
Q2 24
4.7%
-50.3%
Net Margin
AVNW
AVNW
PRCT
PRCT
Q1 26
-38.1%
Q4 25
5.1%
-39.1%
Q3 25
0.2%
-25.7%
Q2 25
4.5%
-24.7%
Q1 25
3.1%
-35.8%
Q4 24
3.8%
-27.6%
Q3 24
-13.4%
-35.9%
Q2 24
1.3%
-48.0%
EPS (diluted)
AVNW
AVNW
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$0.44
$-0.54
Q3 25
$0.01
$-0.38
Q2 25
$0.42
$-0.35
Q1 25
$0.27
$-0.45
Q4 24
$0.35
$-0.34
Q3 24
$-0.94
$-0.40
Q2 24
$0.11
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AVNW
AVNW
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$86.5M
$245.6M
Total DebtLower is stronger
$105.4M
$51.7M
Stockholders' EquityBook value
$271.6M
$347.7M
Total Assets
$659.4M
$487.1M
Debt / EquityLower = less leverage
0.39×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AVNW
AVNW
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$86.5M
$286.5M
Q3 25
$64.8M
$294.3M
Q2 25
$59.7M
$302.7M
Q1 25
$49.4M
$316.2M
Q4 24
$52.6M
$333.7M
Q3 24
$51.0M
$196.8M
Q2 24
$64.6M
$214.1M
Total Debt
AVNW
AVNW
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$105.4M
$51.6M
Q3 25
$106.5M
$51.6M
Q2 25
$87.6M
$51.5M
Q1 25
$73.9M
$51.5M
Q4 24
$74.9M
$51.5M
Q3 24
$83.4M
$51.4M
Q2 24
$48.4M
$51.4M
Stockholders' Equity
AVNW
AVNW
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$271.6M
$365.9M
Q3 25
$263.6M
$380.3M
Q2 25
$263.2M
$385.8M
Q1 25
$256.1M
$389.2M
Q4 24
$249.6M
$402.2M
Q3 24
$247.1M
$241.2M
Q2 24
$255.9M
$251.8M
Total Assets
AVNW
AVNW
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$659.4M
$508.1M
Q3 25
$643.3M
$511.5M
Q2 25
$633.3M
$513.1M
Q1 25
$628.3M
$519.4M
Q4 24
$594.1M
$534.0M
Q3 24
$590.9M
$374.1M
Q2 24
$535.2M
$374.4M
Debt / Equity
AVNW
AVNW
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.39×
0.14×
Q3 25
0.40×
0.14×
Q2 25
0.33×
0.13×
Q1 25
0.29×
0.13×
Q4 24
0.30×
0.13×
Q3 24
0.34×
0.21×
Q2 24
0.19×
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AVNW
AVNW
PRCT
PRCT
Operating Cash FlowLast quarter
$23.9M
Free Cash FlowOCF − Capex
$22.5M
FCF MarginFCF / Revenue
20.2%
Capex IntensityCapex / Revenue
1.3%
Cash ConversionOCF / Net Profit
4.18×
TTM Free Cash FlowTrailing 4 quarters
$16.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AVNW
AVNW
PRCT
PRCT
Q1 26
Q4 25
$23.9M
$-10.3M
Q3 25
$-11.7M
$-6.6M
Q2 25
$10.5M
$-15.0M
Q1 25
$1.6M
$-17.0M
Q4 24
$20.8M
$-32.4M
Q3 24
$-27.2M
$-18.8M
Q2 24
$8.3M
$-15.7M
Free Cash Flow
AVNW
AVNW
PRCT
PRCT
Q1 26
Q4 25
$22.5M
$-12.2M
Q3 25
$-13.5M
$-9.5M
Q2 25
$8.2M
$-17.8M
Q1 25
$-1.2M
$-18.8M
Q4 24
$18.3M
$-33.6M
Q3 24
$-32.6M
$-19.0M
Q2 24
$7.5M
$-16.8M
FCF Margin
AVNW
AVNW
PRCT
PRCT
Q1 26
Q4 25
20.2%
-15.9%
Q3 25
-12.6%
-11.4%
Q2 25
7.1%
-22.5%
Q1 25
-1.0%
-27.2%
Q4 24
15.5%
-49.2%
Q3 24
-36.8%
-32.6%
Q2 24
6.4%
-31.4%
Capex Intensity
AVNW
AVNW
PRCT
PRCT
Q1 26
Q4 25
1.3%
2.4%
Q3 25
1.6%
3.4%
Q2 25
2.0%
3.5%
Q1 25
2.5%
2.7%
Q4 24
2.1%
1.7%
Q3 24
6.1%
0.4%
Q2 24
0.7%
2.0%
Cash Conversion
AVNW
AVNW
PRCT
PRCT
Q1 26
Q4 25
4.18×
Q3 25
-72.48×
Q2 25
2.02×
Q1 25
0.46×
Q4 24
4.62×
Q3 24
Q2 24
5.37×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AVNW
AVNW

Products$81.2M73%
Services$30.3M27%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons